Search for: "NASDAQ" Results 541 - 560 of 3,406
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jan 2022, 5:50 am
-based firms listed on either the NYSE or NASDAQ exchanges (about 3,100 firms per year) from the first quarter of 2013 through the end of September 2021. [read post]
14 Jan 2022, 8:02 am by Zamansky LLC
Private Placements A private placement is an investment in a company that does not offer its shares on a public market such as the NASDAQ or NYSE. [read post]
13 Jan 2022, 3:15 am by Dan Shores
Sanofi (NASDAQ: SNY), headquartered in Paris, FR, acquired mRNA pioneer Translate... [read post]
13 Jan 2022, 3:15 am by Dan Shores
Sanofi (NASDAQ: SNY), headquartered in Paris, FR, acquired mRNA pioneer Translate Bio in September 2021 for approximately $3.2 billion and mRNA startup Tidal Therapeutics in April 2021 for approximately $470 million. [read post]
12 Jan 2022, 5:50 am
Related research from the Program on Corporate Governance includes Politics and Gender in the Executive Suite by Alma Cohen, Moshe Hazan, and David Weiss (discussed on the Forum here); and Will Nasdaq’s Diversity Rules Harm Investors? [read post]
11 Jan 2022, 7:10 am by Rob Robinson
Editor’s Note: Given the challenge of monitoring and tracking merger, acquisition, and investment activity for eDiscovery-related companies, from time to time the quarterly and annual reporting of the number of events may change slightly as new information becomes available concerning these events. [read post]
11 Jan 2022, 5:55 am
Related research from the Program on Corporate Governance includes Politics and Gender in the Executive Suite by Alma Cohen, Moshe Hazan, and David Weiss (discussed on the Forum here); and Will Nasdaq’s Diversity Rules Harm Investors? [read post]
10 Jan 2022, 5:53 am
Against the backdrop of investors increased diversity expectations and NASDAQ’s board diversity rules, ISS is expanding its current policy requiring at least one female director to all companies, not just those in the S&P 1500 or Russell 3000 indicies, starting with meetings on or after Feb. 1, 2023. [read post]
3 Jan 2022, 12:39 pm by Kevin LaCroix
The directors’ and officers’ liability environment is always changing, but 2021 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
3 Jan 2022, 5:49 am
In addition, consumer spending increased by ~0.4% from Q2 to Q3 and we witnessed strong market performance from early-July to the beginning of September. [1] In recent months, the U.S. equity markets reverted back to the winners of the initial COVID era with large-cap equities outperforming both mid- and small-cap equities and growth equities outperforming value equities. [2] [3] While year-over-year inflation reached a 30-year high of 6.2% in October and supply chain disruption worries shook… [read post]
2 Jan 2022, 12:55 pm by Stuart Kaplow
Instead of the development of stone tools, we will see the development of the emergent and fast paced area of the law trying to catch up with society’s movement of ESG issues. 2022 will also see the effective date of Nasdaq’s SEC approved ESG rule on board diversity. [read post]
1 Jan 2022, 8:20 am by Rob Robinson
Editor’s Note: Since beginning in November 2001 to track the number of publicly highlighted merger, acquisition, and investment (M&A+I) events in the eDiscovery ecosystem, ComplexDiscovery has recorded 508* M&A+I events. [read post]
29 Dec 2021, 9:22 am by Bob Ambrogi
Before 2021, the last time a legal technology company went public in the U.S. was nearly two decades earlier, in 2002, when the document management company iManage debuted on the Nasdaq market. [read post]
29 Dec 2021, 9:22 am by Bob Ambrogi
Before 2021, the last time a legal technology company went public in the U.S. was nearly two decades earlier, in 2002, when the document management company iManage debuted on the Nasdaq market. [read post]
28 Dec 2021, 3:30 am by Liz Dunshee
I blogged earlier this month that Nasdaq’s annual listing fees are increasing January 1st. [read post]
27 Dec 2021, 4:15 am by Dan Shores
Sanofi (NASDAQ: SNY), headquartered in Paris, FR, acquired mRNA pioneer Translate Bio in September 2021 for approximately $3.2 billion and mRNA startup Tidal Therapeutics in April 2021 for approximately $470 million. [read post]
27 Dec 2021, 4:15 am by Dan Shores
Sanofi (NASDAQ: SNY), headquartered in Paris, FR, acquired mRNA pioneer Translate Bio in September 2021 for approximately $3.2 billion and mRNA startup Tidal Therapeutics in April 2021 for approximately $470 million. [read post]